ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 79.50
+4.20 (5.58%)
Sep 5, 2025, 1:47 PM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 4.92 billion as of September 5, 2025. Its market cap has increased by 215.91% in one year.
Market Cap
4.92B
Enterprise Value
4.44B
Revenue
44.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
79.50
Market Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 1.38B to 4.92B, an increase of 256.63%. That is a compound annual growth rate of 36.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 4.92B | 214.68% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.98M | -31.96% |
| Jul 27, 2021 | 1.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 395.51B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 90.84B |
| Lotus Pharmaceutical | 50.62B |
| Lumosa Therapeutics | 40.77B |
| Oneness Biotech | 36.44B |
| Polaris Group | 29.47B |
| Center Laboratories | 28.63B |